T cell receptor variable β gene repertoire in liver and peripheral blood lymphocytes of chronically hepatitis C virus‐infected patients with and without mixed cryoglobulinaemia
暂无分享,去创建一个
V. Conteduca | D. Sansonno | S. Russi | G. Lauletta | S. Sansonno | V. De Re | G. Serviddio | L. Sansonno | D Sansonno | S Russi | G Lauletta | G Serviddio | S Sansonno | V Conteduca | L Sansonno | V De Re
[1] Bryan Lau,et al. Exceeding the limits of liver histology markers. , 2009, Journal of hepatology.
[2] B. Walker,et al. Hepatitis C virus infection. , 2001, The New England journal of medicine.
[3] A. Talal,et al. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection , 2007, Journal of viral hepatitis.
[4] Y. Liaw,et al. Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity. , 1998, Gastroenterology.
[5] J. Demengeot,et al. Regulatory T Cells Accumulate in the Lung Allergic Inflammation and Efficiently Suppress T-Cell Proliferation but Not Th2 Cytokine Production , 2011, Clinical & developmental immunology.
[6] B. Rehermann,et al. Chronic HCV infection and the clonality of intrahepatic T cells. , 2003, Journal of hepatology.
[7] Felicia A Tucci,et al. Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection , 2004, European journal of immunology.
[8] T. Hodge,et al. Human immunodeficiency virus type 1 RNA expression by four chronically infected cell lines indicates multiple mechanisms of latency , 1994, Journal of virology.
[9] D. Sansonno,et al. Immunochemical and biomolecular studies of circulating immune complexes isolated from patients with acute and chronic hepatitis C virus infection , 1996, European journal of clinical investigation.
[10] V. Conteduca,et al. Hepatitis C Virus Infection and Mixed Cryoglobulinemia , 2012, Clinical & developmental immunology.
[11] C. Walker,et al. Adaptive immune responses in acute and chronic hepatitis C virus infection , 2005, Nature.
[12] C. Malone,et al. IgM rheumatoid factors react with human class I HLA molecules. , 1996, Journal of immunology.
[13] Zimmerman Hj,et al. Morphologic spectrum of drug-induced hepatic disease. , 1995 .
[14] M. Masucci,et al. HLA-A11 epitope loss isolates of Epstein-Barr virus from a highly A11+ population. , 1993, Science.
[15] É. Vivier,et al. Features and distribution of CD8 T cells with human leukocyte antigen class I–specific receptor expression in chronic hepatitis C , 2007, Hepatology.
[16] A. Tzakis,et al. The Immune Reactivity Role of HCV-Induced Liver Infiltrating Lymphocytes in Hepatocellular Damage , 1997, Journal of Clinical Immunology.
[17] D. Thorley-Lawson,et al. A novel form of Epstein-Barr virus latency in normal B cells in vivo , 1995, Cell.
[18] D. Sansonno,et al. Clonal analysis of intrahepatic B cells from HCV-infected patients with and without mixed cryoglobulinemia. , 1998, Journal of immunology.
[19] C. Katlama,et al. Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy , 1998, Nature Medicine.
[20] J. Rockstroh,et al. Differential expansion of T‐cell receptor variable beta subsets after antigenic stimulation in patients with different outcomes of hepatitis C infection , 2002, Immunology.
[21] M Hummel,et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: Report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2003, Leukemia.
[22] G. McFadden,et al. How DNA viruses perturb functional MHC expression to alter immune recognition. , 1994, Advances in cancer research.
[23] D. Geschwind,et al. Longitudinal system-based analysis of transcriptional responses to type I interferons. , 2009, Physiological genomics.
[24] R. Thimme,et al. Success and Failure of Virus-Specific T Cell Responses in Hepatitis C Virus Infection , 2011, Digestive Diseases.
[25] J. Borovička,et al. Polyfunctional HCV‐specific T‐cell responses are associated with effective control of HCV replication , 2008, European journal of immunology.
[26] P. Marche,et al. Simultaneous evaluation of lymphocyte subpopulations in the liver and in peripheral blood mononuclear cells of HCV‐infected patients: relationship with histological lesions , 2002, Clinical and experimental immunology.
[27] S. Hughes,et al. Retroviral reverse transcription and integration: progress and problems. , 1992, Annual review of cell biology.
[28] L. K. Ely,et al. The molecular basis of TCR germline bias for MHC is surprisingly simple , 2009, Nature Immunology.
[29] J. Piette,et al. CD4+CD25+ regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. , 2004, Blood.
[30] D. Sansonno,et al. Hepatitis C virus infection, cryoglobulinaemia, and beyond. , 2006, Rheumatology.
[31] Steven L Flamm,et al. Chronic hepatitis C virus infection. , 2003, JAMA.
[32] D. Sansonno,et al. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. , 2005, The Lancet. Infectious diseases.
[33] T. Macnaughton,et al. A molecular comparison of T lymphocyte populations infiltrating the liver and circulating in the blood of patients with chronic hepatitis B: Evidence for antigen‐driven selection of a public complementarity‐determining region 3 (CDR3) motif , 2001, Hepatology.
[34] Philippa Marrack,et al. Many different Vβ CDR3s can reveal the inherent MHC reactivity of germline-encoded TCR V regions , 2009, Proceedings of the National Academy of Sciences.
[35] Y. S. Hahn,et al. Subversion of immune responses by hepatitis C virus: immunomodulatory strategies beyond evasion? , 2003, Current opinion in immunology.
[36] Charles R. M. Bangham,et al. Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition , 1991, Nature.
[37] M. K. Spriggs. Cytokine and cytokine receptor genes 'captured' by viruses. , 1994, Current opinion in immunology.
[38] D. Sansonno,et al. The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and Overt B-cell malignancy. , 2000, Seminars in liver disease.
[39] A. Vallejo,et al. The Influence of Age on T Cell Generation and TCR Diversity1 , 2005, The Journal of Immunology.
[40] K. Ishak,et al. Morphologic spectrum of drug-induced hepatic disease. , 1995, Gastroenterology clinics of North America.
[41] Felicia A Tucci,et al. Increased serum levels of the chemokine CXCL13 and up-regulation of its gene expression are distinctive features of HCV-related cryoglobulinemia and correlate with active cutaneous vasculitis. , 2008, Blood.
[42] M. Hellard,et al. Antigen-Driven Patterns of TCR Bias Are Shared across Diverse Outcomes of Human Hepatitis C Virus Infection , 2011, The Journal of Immunology.
[43] B. Boehm,et al. Oligoclonal CD8+ T-Cell Expansion in Patients with Chronic Hepatitis C Is Associated with Liver Pathology and Poor Response to Interferon-α Therapy , 2004, Journal of Clinical Immunology.
[44] P. Marcellin,et al. The intraportal lymphoid nodule and its environment in chronic active hepatitis C: An immunohistochemical study , 1993, Hepatology.
[45] A. Rothman,et al. Evolution of the intrahepatic T cell repertoire during chronic hepatitis C virus infection. , 2005, Viral immunology.
[46] I. Warshawsky,et al. A Comparison of Multiplex and Monoplex T-Cell Receptor Gamma PCR , 2004, Diagnostic molecular pathology : the American journal of surgical pathology, part B.
[47] S. Kalams,et al. Limited T Cell Receptor Diversity of HCV-specific T Cell Responses Is Associated with CTL Escape , 2004, The Journal of experimental medicine.
[48] F. Chisari,et al. Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence , 1999, Hepatology.
[49] C. Walker,et al. Cell-mediated immunity and the outcome of hepatitis C virus infection. , 2004, Annual review of microbiology.